Go to home page
Skip to Content
Skip to Main Navigation
Skip to Local Navigation
Skip to Search

Better health and ageing for all Australians

Listen to this page

Home > For Consumers > Health products and medicines > Medicines > Pharmaceutical Benefits Scheme (PBS) > PBS Publications and Forms > PBS Publications > PBAC Outcomes and Public Summary Documents > Public Summary Documents > Public Summary Documents by Meeting

Public Summary Documents by Meeting

PBAC Public Summary Documents - December 2009

Public summary documents relating to the December 2009 PBAC meeting

In this section:

PBAC Public Summary Documents - December 2009

PBAC Public Summary Documents - November 2009

PBAC Public Summary Documents - July 2009

PBAC Public Summary Documents - March 2009

PBAC Public Summary Documents - November 2008

PBAC Public Summary Documents - July 2008

PBAC Public Summary Documents - March 2008

PBAC Public Summary Documents - November 2007

PBAC Public Summary Documents - July 2007

PBAC Public Summary Documents - March 2007

PBAC Public Summary Documents - November 2006

PBAC Public Summary Documents - July 2006

PBAC Public Summary Documents - March 2006

PBAC Public Summary Documents - November 2005

PBAC Public Summary Documents - July 2005

PBAC Review of bDMARDs for the treatment of severe, active rheumatoid arthritis [abatacept (Orencia®), anakinra (Kineret®), adalimumab (Humira®), etanercept (Enbrel®), infliximab (Remicade®), rituximab (Mabthera®)]